Ignite Creation Date:
2025-12-26 @ 10:33 AM
Ignite Modification Date:
2026-03-05 @ 9:11 PM
Study NCT ID:
NCT01269528
Status:
COMPLETED
Last Update Posted:
2015-11-10
First Post:
2011-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prospective Evaluation of the Efficacy of Palivizumab Administration in Children Born at 29-32 Weeks of Gestation
Sponsor:
Rambam Health Care Campus
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Evaluation of Palivizumab
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None